MedElevator Войти в исследования
← Поиск публикаций

DOI 10.17116/hirurgia202212236

Медицинская библиотека · Khirurgiia · 2022

[Combined treatment of rectal cancer with moderate risk of tumor progression].

Barsukov Yu A, Tkachev S I, Mamedli Z Z, Aliev V A, Vlasov O A, Perevoshchikov A G, Oltarzhevskaya N D, Korovina M A, Dudaev Z A, Ovchinnikova A I

Аннотация на английскомСтатьяОригинал на русском

Аннотация

OBJECTIVE

To increase the effectiveness of combined treatment in patients with rectal cancer and moderate risk of progression based on the concept of polyradiomodification (PRM).

MATERIAL AND

METHODS

The study included 337 patients with rectal cancer and moderate risk of tumor progression. A short course of radiotherapy (cRT) (5x5 Gy) combined with several radiomodifiers (cRT+PRM) was performed in 147 (43.6%) patients. Other 190 (56.4%) patients underwent cRT. The following radio modifiers were used: three-time application of local microwave hyperthermia (Yacht-3 or Yacht-4 devices), two-time intrarectal delivery of a biopolymer composition with Metronidazole before the 3rd and 5th irradiation sessions and two-week oral administration of Capecitabine (Xeloda) at a daily dose of 2.0 g/m2. Surgery was performed in 4-6 weeks after radiotherapy.

RESULTS

CRT+PRM program increased 5-year relapse-free survival up to 81.3% compared to 60.3% after cRT alone (p=0.0003) due to significant reduction of the incidence of cancer recurrence from 8.4% to 0.7% (p=0.0013). More effective local growth control expanded the indications for sphincter-sparing surgery. These procedures were performed in 89.1% and 70.5% of patients, respectively (p=0.00001). In the cRT+PRM group, sphincter-sparing surgery reduced incidence of cancer recurrence from 13.7% to 0.8% (p=0.0110), distant metastases - from 23.9% to 13.7% (p=0.00349).

CONCLUSION

Radiomodification in neoadjuvant radiotherapy is justified in patients with moderate risk of tumor progression, improves long-term results and increases the incidence of sphincter-sparing surgery.

Для цитирования: Barsukov Yu A, Tkachev S I, Mamedli Z Z, Aliev V A, Vlasov O A, Perevoshchikov A G, Oltarzhevskaya N D, Korovina M A, Dudaev Z A, Ovchinnikova A I. [Combined treatment of rectal cancer with moderate risk of tumor progression].. Khirurgiia. 2022. DOI: 10.17116/hirurgia202212236.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.